ENDRA Life Sciences

NASDAQ: NDRA
Nasdaq Stock Market
Healthcare Diagnostics & Research
Global Rank
#45428
Country Rank
#5563
Market Cap
3.48 M
Price
4.62
Change (%)
4.25%
Volume
2,239

ENDRA Life Sciences's latest marketcap:

3.48 M

As of 08/19/2025, ENDRA Life Sciences's market capitalization has reached $3.48 M. According to our data, ENDRA Life Sciences is the 45428th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 3.48 M
Revenue (ttm) 0
Net Income (ttm) -8,765,336
Shares Out 752,755
EPS (ttm) -17.01
Forward PE 0.00
Ex-Dividend Date n/a
Earnings Date 08/14/2025
Market Cap Chart
Data Updated: 08/19/2025

ENDRA Life Sciences's yearly market capitalization.

ENDRA Life Sciences has seen its market value drop from $18.88 M to $3.48 M since 2017, representing a total decrease of 81.58% and an annual compound decline rate (CAGR) of 19.86%.
Date Market Cap($) Change (%) Global Rank
08/19/2025 $3.48 M 8.85% 45428
12/31/2024 $3.36 M -81.25% 42038
12/29/2023 $17.92 M 39.49% 34304
12/30/2022 $12.85 M -55.92% 34874
12/31/2021 $29.15 M 15.68% 30771
12/31/2020 $25.2 M 100.27% 28408
12/31/2019 $12.58 M 13.06% n/a
12/31/2018 $11.13 M -41.06% n/a
12/29/2017 $18.88 M n/a

Company Profile

ENDRA Life Sciences was founded in 2007 in United States. The company went public on 05/09/2017 on the Nasdaq Stock Market. With 21 employees, it focuses on Healthcare and aims to drive innovation in Diagnostics & Research.

Frequently Asked Questions

  • What is ENDRA Life Sciences's (NDRA) current market cap?
    As of 08/19/2025, ENDRA Life Sciences (including the parent company, if applicable) has an estimated market capitalization of $3.48 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
  • ENDRA Life Sciences global market capitalization ranking is approximately 45428 as of 08/19/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.